Cargando…
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
We describe a case of acute relapse in a woman with Multiple Sclerosis (MS) shortly after the mRNA COVID-19 vaccination. The patient received a diagnosis of MS in November 2016 at the MS Centre of the A. Cardarelli Hospital (South of Italy). Since that moment, her clinical conditions and pharmacolog...
Autores principales: | Maniscalco, Giorgia T., Manzo, Valentino, Di Battista, Maria E., Salvatore, Simona, Moreggia, Ornella, Scavone, Cristina, Capuano, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382847/ https://www.ncbi.nlm.nih.gov/pubmed/34447349 http://dx.doi.org/10.3389/fneur.2021.721502 |
Ejemplares similares
-
Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study
por: Ziello, Antonio, et al.
Publicado: (2021) -
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2023) -
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022) -
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022) -
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022)